Gene Therapy Re-launched For Bubble Boy Syndrome
11:02 AM Posted In Bubble boy , Childrens hospital boston , gene therapy , research study , SCID , the boy in the bubble Edit This 4 Comments »
source
You might remember the made-for-TV movie, “The Boy in the Plastic Bubble,” starring John Travolta. The movie was inspired by real life SCID (also called bubble boy syndrome) sufferers- David Vetter and Ted DeVita. The genetic condition leaves the child unable to fight off germs.
The last study about SCID and gene therapy was seven years ago in Europe. The two trials involved a total of 20 children. It was stopped after two participants were diagnosed with leukemia. Three others eventually developed leukemia as well. The survivors were cured of SCID-X1, but the European episode prompted the U.S. FDA to put certain gene-therapy studies on hold.
Finally, researchers believe that they have removed the treatment feature thought to have caused the leukemia, and we have a new gene-therapy trial for SCID in the U.S. going forward. Five other international sites will also participate. The new study is sponsored by investigators at Children's Hospital Boston. Scientists plan to enroll 20 boys with SCID-X1. Scientists will try to correct the defective or non-functioning gene in SCID by delivering a “vector,” a virus genetically altered to contain human DNA. In theory, the normal gene with the vector will begin producing a protein that has been missing or not working. Thus, curing the disease.
Read more about SCID and the new study:
Wall Street Journal- Study Shows Hope For Gene Therapy
Severe Combined Immune Deficiency - Types And Severity Of Immunodeficiency Diseases, Scid, Gene Therapy
Science Daily- Why Gene Therapy Caused Leukemia in Some Boy in the Bubble Syndrome Patients
Children's Hospital Boston- International Gene Therapy Trial Launched at Children's Hospital Boston for "Bubble Boy" Syndrome
You might remember the made-for-TV movie, “The Boy in the Plastic Bubble,” starring John Travolta. The movie was inspired by real life SCID (also called bubble boy syndrome) sufferers- David Vetter and Ted DeVita. The genetic condition leaves the child unable to fight off germs.
The last study about SCID and gene therapy was seven years ago in Europe. The two trials involved a total of 20 children. It was stopped after two participants were diagnosed with leukemia. Three others eventually developed leukemia as well. The survivors were cured of SCID-X1, but the European episode prompted the U.S. FDA to put certain gene-therapy studies on hold.
Finally, researchers believe that they have removed the treatment feature thought to have caused the leukemia, and we have a new gene-therapy trial for SCID in the U.S. going forward. Five other international sites will also participate. The new study is sponsored by investigators at Children's Hospital Boston. Scientists plan to enroll 20 boys with SCID-X1. Scientists will try to correct the defective or non-functioning gene in SCID by delivering a “vector,” a virus genetically altered to contain human DNA. In theory, the normal gene with the vector will begin producing a protein that has been missing or not working. Thus, curing the disease.
Read more about SCID and the new study:
Wall Street Journal- Study Shows Hope For Gene Therapy
Severe Combined Immune Deficiency - Types And Severity Of Immunodeficiency Diseases, Scid, Gene Therapy
Science Daily- Why Gene Therapy Caused Leukemia in Some Boy in the Bubble Syndrome Patients
Children's Hospital Boston- International Gene Therapy Trial Launched at Children's Hospital Boston for "Bubble Boy" Syndrome